Literature DB >> 9392912

Prenatal diagnosis of Duchenne muscular dystrophy in the Japanese population by fluorescent CA repeat polymorphisms analysis.

Y Shiroshita1, S Katayama.   

Abstract

OBJECTIVE: To investigate the efficacy of CA repeat analysis using fluorescence-labeled primers in the prenatal diagnosis of Duchenne muscular dystrophy in the Japanese population.
METHODS: Allelic frequencies of polymorphic loci in the Duchenne muscular dystrophy gene were ascertained, and the polymorphic information content (PIC) was calculated. CA repeat analysis of 21 Japanese families with Duchenne muscular dystrophy was then performed.
RESULTS: The STR 49 locus had the highest PIC, followed in decreasing order by the loci of STR 44, STR 45, STR 50, DYS III, DYS II, DYS I, and 3' CA. The diagnostic applicability increased to 0.999 when the PICs of all 8 loci were combined. When the highest PIC from each of the 5' end, exons near the 3' end and the 3' end were combined, the diagnostic applicability increased to 0.988. Of the 7 males examined prenatally, 1 was diagnosed as normal, and 6 were affected, while of the 9 females examined, 5 were diagnosed as carriers, and 4 as non-carriers.
CONCLUSION: CA repeat analysis using fluorescence-labeled primers is useful in the prenatal diagnosis of Duchenne muscular dystrophy in the Japanese population.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9392912     DOI: 10.1111/j.1447-0756.1997.tb00873.x

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  1 in total

1.  A larger spectrum of intragenic short tandem repeats improves linkage analysis and localization of intragenic recombination detection in the dystrophin gene: an analysis of 93 families from southern Italy.

Authors:  Antonella Carsana; Giulia Frisso; Maria Roberta Tremolaterra; Elisabetta Ricci; Domenico De Rasmo; Francesco Salvatore
Journal:  J Mol Diagn       Date:  2007-02       Impact factor: 5.568

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.